Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2019 - 2026)

Aurinia Pharmaceuticals (AUPH) has 10 years of Other Non-Current Assets data on file, last reported at $93000.0 in Q1 2026.

• Quarterly Other Non-Current Assets fell 88.7% year-over-year to $93000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (down 88.7% YoY) and the FY2025 annual result came in at $93000.0, down 88.7% from the prior year.
• Other Non-Current Assets steadied at $93000.0 in Q1 2026, from $93000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $13.0 million in Q3 2022 to a low of $84000.0 in Q4 2022.
• A 5-year average of $2.8 million and a median of $867000.0 in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 99.29% — and 2023, when it jumped 1705.95%.
• Tracing AUPH's Other Non-Current Assets over 5 years: stood at $84000.0 in 2022, then jumped by 1705.95% to $1.5 million in 2023, then sank by 45.75% to $823000.0 in 2024, then tumbled by 88.7% to $93000.0 in 2025, then changed by 0.0% to $93000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $93000.0 (Q1 2026), $93000.0 (Q4 2025), and $93000.0 (Q3 2025), per Business Quant data.